top of page
< Back

Are GLP-1 Patches Actually Legal? What a 2026 Study Found

FAQ-000045

Direct Answer

Beyond the question of whether GLP-1 patches work, a 2026 peer-reviewed study published in the Annals of Pharmacotherapy raises a more fundamental legal issue: selling a topical patch or gel as a dietary supplement is illegal under federal law, regardless of its ingredients, because dietary supplements are legally required to be taken orally, not applied to the skin. The researchers identified 24 transdermal patch products and one gel, none of which contained an actual GLP-1 agonist.

What the Study Actually Found

Across the 24 patches examined, the most common listed ingredients were berberine, pomegranate extract, glutamine or glutamate, cinnamon, and chromium, an average of seven natural ingredients per product. None of these are GLP-1 receptor agonists, and none replicate how semaglutide or tirzepatide actually works in the body. Berberine, the best-studied ingredient among them, has shown modest effects on weight in some research, but nothing close to the results seen with actual GLP-1 medications.

Why "Transdermal" Specifically Matters Here

This is a distinct issue from most other GLP-1-branded products covered in this library. A misleading supplement pill is still, legally, a supplement. A patch or gel marketed as a "dietary supplement" isn't, by definition, since the entire regulatory category requires oral ingestion. Some 2026 versions of these products have escalated their claims further, describing "semaglutide-like compounds" or "GLP-1 peptide fragments" in their marketing, claims that remain unverified and are not associated with any FDA-approved product.

Regulatory Response

The FTC has issued warning letters specifically targeting "natural Ozempic" marketing and has taken enforcement action against companies making unsubstantiated GLP-1 patch and gummy claims. Legal analysis of this product category has noted that marketing any product using GLP-1 branding in a way that implies it works like semaglutide or tirzepatide may constitute deceptive advertising under FTC standards and state consumer protection law, independent of whatever the product's ingredients actually are.

A Common Billing Pattern Worth Knowing

Many of these products are sold through "free trial" offers that automatically charge $60 to $120 per month afterward, with cancellation made deliberately difficult, requiring a phone call that goes unanswered, or a cancellation window set 30 days before the next billing date. This pattern shows up across the patch and gummy category broadly, not any single brand.

Bottom Line

If a product is a patch, gel, or anything applied to the skin and marketed as a GLP-1 alternative, it's worth treating with real skepticism on two separate grounds: it doesn't contain an actual GLP-1 agonist, and its entire product category may not be legally sellable as a supplement in the first place.

References

  • Annals of Pharmacotherapy: Transdermal GLP-1 Dietary Supplement Products, 2026 Review
  • The Lyon Firm: "Natural GLP-1" Supplement Scams, Deceptive Marketing and Legal Rights
  • The GLP Spot: GLP-1 Booster Supplements, What the Evidence Actually Shows (2026)

Related Resources

Related Articles

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 option, real and marketed-as-real.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical or legal advice.

are-glp-1-patches-legal

bottom of page